| Literature DB >> 29657713 |
Stanley Chitekwe1, Sibhatu Biadgilign1, Assaye Tolla1, Mark Myatt2.
Abstract
Background: Severe acute malnutrition (SAM) threatens the lives of millions of children worldwide particularly in low and middle-income countries (LMICs). Community-based management of acute malnutrition (CMAM) is an approach to treating large numbers of cases of severe acute malnutrition (SAM) in a community setting. There is a debate about the use of mid-upper arm circumference (MUAC) for admitting and discharging SAM children. This article describes the experience of using MUAC for screening, case-finding, referral, admission, and discharge in a large-scale CMAM program delivered through existing primary health care facilities in Nigeria.Entities:
Keywords: Admission; CMAM; Case-detection; Discharging; MUAC; Nigeria
Year: 2018 PMID: 29657713 PMCID: PMC5890342 DOI: 10.1186/s13690-018-0266-4
Source DB: PubMed Journal: Arch Public Health ISSN: 0778-7367
Fig. 1Map of Nigeria Outpatient Therapeutic Program operational area
Admission and discharge criteria (i.e. for patients discharged as cured) used in the Nigerian outpatient therapeutic program
| Admission criteria | Discharge criteria |
|---|---|
| MUAC < 115 mm | MUAC > 115 mm and no edema, evidence of sustained weight gain, and clinically wella |
| Bilateral pitting edema | MUAC > 115 mm and no oedema for two consecutive visits (i.e. at least two weeks), and clinically well |
| WHZ < − 3 | MUAC > 115 mm and WHZ > − 2 and no oedema for two consecutive visits, and clinically well |
aThis differs from the WHO recommendation of MUAC ≥125 mm. This was considered acceptable as the program is delivered in local primary healthcare centres and caregivers were instructed to return to the clinic of the child became ill or did not continue to gain weight after discharge
Post-test effect sizes used to identify associations with substantive significance
| Factor | Outcome | Test | Effect size | Standarda |
|---|---|---|---|---|
| Categorical | Categorical | Chi-square | Risk difference (RD) | |RD| > 5% |
| Categorical | Continuous | Kruskal-Wallis H | Cohen’s | | |
| Continuous | Continuous | Wald type test for | Pearson’s | | | |
aStandards were applied post-test (i.e. only for associations with p < 0.05)
bDifference between means divided by the pooled standard deviation [30]
cPearson product moment correlation coefficient
Characteristics of the sample of admissions from the Nigeria outpatient therapeutic program (2010 to 2013)
| Attribute | Details | Number | Percentage |
|---|---|---|---|
| Sample size | Number of children | 102,245 | 100.00% |
| Sex | Males | 49,240 | 48.2% |
| Females | 47,137 | 46.1% | |
| Missing | 5868 | 5.7% | |
| Age (year-centered age-group) at admission (months)a | [6,17] centred at 1 year | 60,750 | 59.4% |
| (17,29] centred at 2 years | 32,170 | 31.5% | |
| (29,41] centred at 3 years | 2520 | 2.4% | |
| (41,53] centred at 4 years | 306 | 0.3% | |
| (53,59] centred at 5 years | 56 | 0.1% | |
| Age at admission (months) | Median age at admission | 13 | |
| Time to travel (hours)a | [0,0.5] | 18,968 | 18.5% |
| (0.5,1] | 20,870 | 20.4% | |
| (1,2] | 14,503 | 14.2% | |
| (2,3] | 6348 | 6.2% | |
| (3,4] | 1874 | 1.8% | |
| (4,5] | 703 | 0.7% | |
| (5,6] | 314 | 0.3% | |
| (6,7] | 155 | 0.1% | |
| Missing | 38,510 | 37.7% |
aIntervals (ranges) are expressed in ISO 31–11 form. The form (a,b] expresses a < x ≤ b
The form [a,b] expresses a ≤ x ≤ b
Fig. 2Age at admission for the cohort of children in Nigeria Outpatient Therapeutic Program (2010 to 2013)
Fig. 3Histogram showing travel times in hours by the clients in Nigeria Outpatient Therapeutic Program (2010 to 2013)
Fig. 4Histogram describing mid-upper arm circumference at admission for severe acute malnutrition cases in Nigeria Outpatient Therapeutic Program (2010 to 2013)
Description of the cohort at admission (admission criteria, anthropometry, and comorbidity) in the sample of admissions from the Nigeria Outpatient Therapeutic Program (2010 to 2013)
| Attribute | Details | Number | Percentage |
|---|---|---|---|
| Admission criteria | MUAC only | 97,239 | 95.1% |
| MUAC with oedema | 1417 | 1.4% | |
| Oedema only | 180 | 0.2% | |
| Other | 3409 | 3.3% | |
| MUAC at admission (mm) | Minimum | 75.0 | |
| Lower quartile | 102.0 | ||
| Median | 109.0 | ||
| Mean | 106.1 | ||
| Upper quartile | 111.0 | ||
| Maximum | 135.0 | ||
| Missing | 1568 | 1.5% | |
| Weight-for-age z-score at admission | Minimum | −8.413 | |
| Lower quartile | −5.005 | ||
| Median | −4.272 | ||
| Mean | −4.288 | ||
| Upper quartile | −3.583 | ||
| Maximum | −0.085 | ||
| Missing | 14,022 | 13.7% | |
| Comorbidity at admission | Any comorbidity | 38,275 | 37.4% |
| Diarrhoea | 25, 011 | 24.5% | |
| Vomiting | 13,768 | 13.5% | |
| Fever | 20,893 | 20.4% | |
| Respiratory illness | 14,288 | 14.0% | |
| Comorbidity during the treatment episodea | Any comorbidity | 7537 | 7.4% |
| Diarrhoea | 3993 | 3.9% | |
| Vomiting | 1481 | 1.4% | |
| Fever | 3755 | 3.7% | |
| Respiratory illness | 2043 | 2.0% |
aReported only for cases with more than a single visit
Outcomes of treatment in the sample of admissions from the Nigeria Outpatient Therapeutic Program (2010 to 2013)
| Attribute | Details | Number | Percentage |
|---|---|---|---|
| Outcome (type of exit) | Defaulted | 20,229 | 19.8% |
| Non-recovered | 8763 | 8.6% | |
| Recovered | 72,463 | 70.9% | |
| Transferred | 507 | 0.5% | |
| Died | 283 | 0.3% | |
| Negative outcomesa | 29,782 | 29.1% | |
| Weight gain (kg)b | Minimum | −1.20 | |
| Lower quartile | 0.50 | ||
| Median | 1.10 | ||
| Mean | 1.12 | ||
| Upper quartile | 1.60 | ||
| Maximum | 3.90 | ||
| Weight velocity (g/kg/day)c | Minimum | −4.86 | |
| Lower quartile | 2.04 | ||
| Median | 3.44 | ||
| Mean | 3.63 | ||
| Upper quartile | 5.08 | ||
| Maximum | 13.9 | ||
| Proportional weight gaind | Minimum | −18.3% | |
| Lower quartile | 0.09 | ||
| Median | 0.18 | ||
| Mean | 0.20 | ||
| Upper quartile | 0.29 | ||
| Maximum | 0.84 | ||
| MUAC gain (mm)e | Minimum | −10.0 | |
| Lower quartile | 8.00 | ||
| Median | 14.0 | ||
| Mean | 14.0 | ||
| Upper quartile | 20.0 | ||
| Maximum | 39.0 | ||
| Length of stay (visits)f | Minimum | 2.00 | |
| Lower quartile | 5.00 | ||
| Median | 7.00 | ||
| Mean | 6.80 | ||
| Upper quartile | 8.00 | ||
| Maximum | 27.0 |
aAll non-recovered cases (default, non-recovery, transfer, and death)
bOedematous cases, cases with a single visit, and cases with extreme values censored (n = 89,165)
cOedematous cases, cases with a single visit, and cases with extreme values censored. (n = 87,343)
dOedematous cases, cases with a single visit, and cases with extreme values censored (n = 89,066)
eCases with extreme values censored. Analysis is for n = 89,047 cases
fRecovered cases only (n = 72,463)
Length of stay, weight gain, weight velocity, proportional weight gain, and mid-upper arm circumference gain by outcome in the sample of admissions from the Nigeria Outpatient Therapeutic Program (2010 to 2013)
| Outcome | Length of stay (weeks)a | Weight gain (kg)a | Weight velocity (g/kg/day)a | Proportional weight gaina | MUAC gain (mm)a |
|---|---|---|---|---|---|
| Default | 1 (1;5) | 0.7 (0.2;1.2) | 3.1 (1.3; 5.0) | 10% (0.0; 0.2) | 9 (3;15) |
| Non-recovered | 4 (2;7) | 0.3 (0.0;0.6) | 1.6 (0.0; 3.0) | 5% (0.0; 0.1) | 3 (0;8) |
| Recovered | 7 (5;8) | 1.1 (0.5;1.6) | 3.4 (2.0, 5.0) | 20% (0.1; 0.3) | 14 (8;20) |
| Transferred | 7 (4;10) | 0.7 (0.2;1.3) | 2.4 (0.9; 4.0) | 10% (0.0; 0.2) | 8 (1;15) |
| Died | 4 (2;6) | 0.3 (−0.1;0.9) | 1.9 (0.0;4.3) | 5%(−0.0; 0.15) | 4 (0;10) |
aResults are presented as median (inter-quartile range)
Fig. 5Outcomes (as proportions of all exits) in the sample of admissions from the Nigeria Outpatient Therapeutic Program (2013)
Multivariable analysis associated with negative outcomes in the sample of admissions from the Nigeria Outpatient Therapeutic Program (2010 to 2013)
| Variable | Strength of associationa |
|---|---|
| Time-to-travelb | 1.08 (1.07;1.10) |
| MUAC at admissionc | 0.96 (0.96;0.96) |
| Diarrhea at admission | 0.87 (0.83;0.91) |
| Cough at admission | 0.88 (0.83 0.93) |
| Diarrhea during the treatment episode | 1.51 (1.37;1.66) |
| Vomiting during the treatment episode | 1.73 (1.49;2.00) |
| Fever during the treatment episode | 1.28 (1.15;1.42) |
| Cough during the treatment episode | 1.38 (1.21;1.58) |
aResults presented as adjusted odds ratio (AOR) and 95% confidence interval
bAOR is for an increase of one hour in travel time
cAOR is for an increase of 1 mm in MUAC
Reasons for negative outcomes and proposed possible suggestions
| Possible reasons for negative outcome | Practical solution suggested |
|---|---|
| • Distance between home and treatment centres | • Providing CMAM services directly in a greater number of communities using community based health workers (CHWs) or health extension workers (HEWs) to deliver CMAM services in their own communities. |
| • Lower MUAC at admission | • Late treatment seeking (i.e. lower MUAC at admission) is usually associated with high opportunity costs [ |
| • Having diarrhoea, vomiting, fever and cough during the treatment episode that reduced response to treatment. | • Counseling of mothers by clinic staff and community-based volunteers regarding the importance of early treatment seeking for conditions such as diarrhoea, vomiting, fever, and cough at any time and especially during the treatment episode. |